Sia Daneshmand, M.D.

Professor of Urology and Oncology (Clinical Scholar)
Director of Urologic Oncology
Director of Clinical Research
Urologic Oncology Fellowship Director
USC

[Sia Daneshmand, M.D. @siadaneshmand]

It’s with mixed emotions and deep gratitude that I will be leaving USC after 17 years to begin a new exciting chapter @UclaUrology as Director of the Institute of Urologic Oncology and Division Chief of Urologic Oncology. Forever thankful for the trainees, colleagues and patients who have shaped my journey. Grateful to @uroegg and @UCLAHealth leadership for their confidence and vision, and excited to build on their remarkable legacy of excellence.

[Mazyar (Menachem) Zahir, M.D. @MazyarZahir]

Honored to present 8 studies from our exceptional Urologic Oncology team @USC_Urology , led by @siadaneshmand , at @auawest 2026!
Especially proud to present our first of its kind #CIS-only #NMIBC #genomics study, alongside our Bladder CARE and history of urology presentations!

[Sia Daneshmand, M.D. @siadaneshmand]

Very elegant work that has implications on treating oligometastatic disease! @TomFlaigMD @AbhiTrip87 @montypal @SWOG

[Hsieh Lab @HsiehLab]

Ever wonder how heterogeneity defines bladder cancer subtypes?

Ha and Hsieh Lab postdoctoral fellows @pushpa_itagi and Samantha Schuster @fredhutch did, leading to a deep study of bladder cancer clonality, evolution, and heterogeneity published @Nature

https://t.co/gSXSWXJ2ST

[Sia Daneshmand, M.D. @siadaneshmand]

Honored to direct the 7th International Bladder Cancer Update #IBCU2026 in Houston!

An outstanding multidisciplinary faculty advancing #BladderCancer care through science, innovation & clinical trials.

Grateful to all our experts. @UroDocAsh @saumyg @VigneshPackiam @TiansterZhang @TomFlaigMD @drdonnahansel @SurenaMatinMD
@GRUrology

[Alex Zhu @alexzhuDO]

Really interesting trial in progress (PRESERVE trial) @UroAlsyouf @siadaneshmand @GU_BigWhacks

Randomizing patients 1:1 to facial sparing vs. standard inguinal orchiectomy. Endpoint = PRO’s

Personally have seen a difference in my own experience. Excited to see final results

[Sia Daneshmand, M.D. @siadaneshmand]

🌺 As President of @AUAWest, and @DanLinMD as Program chair, we are excited to welcome colleagues to #SurgeWest2026 in Maui, Oct 25–30! 🌴

Outstanding science, innovation, education & fellowship await at the Best Week in Urology! Up to
33.50 AMA PRA Category 1 Credits™

Join us in person or virtually!

🔗 https://t.co/AA8BNccsaU

#WSAUA26 @DanLinMD @MarkTysonMD @garywchien @PReyblat @BrianDutyMD_MBA @EugeUrology @KKseattle @UroCancerMD

[Sia Daneshmand, M.D. @siadaneshmand]

https://t.co/PSzqsiNdCr

[Sia Daneshmand, M.D. @siadaneshmand]

https://t.co/PSzqsiNdCr

[Nirmal Lamichhane @LamichhaneN]

@siadaneshmand Article link?

[Sia Daneshmand, M.D. @siadaneshmand]

Excited to share our latest review in @NatureRevUrol. As the landscape of bladder-preserving therapies rapidly expands, the next frontier in #NMIBC is not simply developing new agents, but understanding how best to combine and sequence them to maximize durable responses and minimize progression. @paolo_gontero @JoshMeeks @SBoorjian @WesKassouf @BladderCancerUS @IBCG_BladderCA @WorldBladderCan https://t.co/JsoimuiYOm

[Sumanta K. Pal, MD, FASCO @montypal]

⭐️SAVE THE DATE: MARCH 5, 2027⭐️

We will be convening the 2027 So Cal GU Research Forum on this date at the Waterfront Hilton in #HuntingtonBeach, CA. If you are a clinician with interest in GU cancers in the #Socal area, you will not want to miss this. Our format is different: our agenda focuses exclusively on #clinicaltrials in the area, and we leave lots of time on the agenda for collaboration.

Looking forward to seeing you there!

[Sia Daneshmand, M.D. @siadaneshmand]

@MarkTysonMD @SteinwayAndSons @AlineBo70833202 What a talented young man! That was amazing. Of course no surprise given the DNA!

[Sia Daneshmand, M.D. @siadaneshmand]

@UroDocAsh @pcvblack @shilpaonc @UrogerliMD @SpiessPhilippe @AparnaKamatMD @UTMDAnderson @urotoday @jdamrauer @SWilliams_MD Many congratulations Ashish. Well deserved!

[Sia Daneshmand, M.D. @siadaneshmand]

Fascial-Sparing Radical Orchiectomy: A Modern Approach to Improving Convalescence - American Urological Association https://t.co/WECKmYyjs7
The PRESERVE trial led by @UroAlsyouf is single blind RCT, comparing PROs between external oblique fascia sparing orchiectomy to standard inguinal orchiectomy. Open and enrolling!
https://t.co/IO9c5LaObh
https://t.co/GxX4Od8GaI

[Sumanta K. Pal, MD, FASCO @montypal]

At the Bladder & Kidney Cancer Academy (hosted by #DrNealShore @CU@CURCMB & @TomJayram). Beautiful talk on #kidneycancer imaging from @KidneyCancerDoc who led the #ZIRCON study, hopefully leading to wide availability of CAIX imaging for our pts. Beyond this, great insights on use of sestamibi & #PSMA imaging.

[Shilpa Gupta, MD, FASCO @shilpaonc]

Celebrating 20 yrs of @IBCG_BladderCA!

Thanks @UroDocAsh for a memorable #IBCG26 and congratulations on IBCG’s tremendous growth & global impact.

What makes this group special is our willingness to tackle difficult & controversial topics with openness, rigor and friendship to build consensuses that help guide the global bladder cancer community.

Grateful for your leadership, mentorship, friendship and proud to serve on the Board. Here’s to the next 20! 🌎🎉

[Sumanta K. Pal, MD, FASCO @montypal]

Great opportunity to train with some of the finest surgeons in the country! @ClaytonLauMD @COHurol @WesleyYipMD @BYuhMD @alexzhuDO

[Sumanta K. Pal, MD, FASCO @montypal]

Kudos to Mamta Parikh, MD (@UCD_Cancer) & @ADESAIONCMD (@UCSFCancer), in association w @ANCO_News, for initiating the 1st #NorCal GU Research Forum. Modeled after the #SoCal meeting started by me & @siadaneshmand w @TDorffOnc, @AmarUKishan, @DrRanaMcKay & others ~5y ago now, this is going to be a phenomenal session in which the major centers across #NorCal convene to share insights on available regional #clinicaltrials.

Great to see a tremendous list of GU experts on the agenda, incl (but not limited to!) @snseyedinMD, @mdallera, @johnleppert, @sandysrimd, @sumitshahMD, @SimaPorten, @koshkin85, @DrTFriedlander, @DivyaParikhMD & so many others!

Join us on 9/19/26 at the @ClaremontHotel. More details here: https://t.co/hjpY4bTTgL

[Shilpa Gupta, MD, FASCO @shilpaonc]

Honored that our @IBCG_BladderCA
consensus paper on "Optimal management of muscle-invasive bladder cancer" has received the @EUplatinum
Impact Award as the most influential work in its June 2026 issue!

Especially meaningful to see the 🌎 impact of this work, bringing together multidisciplinary expertise to help guide evidence-based care, treatment sequencing, and the next generation of clinical trials for patients with MIBC worldwide.

Grateful to our co-authors, IBCG colleagues, and @UroDocAsh for his vision and commitment to improving bladder cancer outcomes.

Thank you @Albert0Briganti for this amazing recognition!

@CleClinicMD @CleClinicUro @caseccc

@EurUrolOncol @Uroweb @WorldBladderCan @FaltasLab @Uromigos @OncoAlert @BladderCancerUS @SpiessPhilippe @GTumors

Full paper here👇
https://t.co/96QJgYiGax

[Sumanta K. Pal, MD, FASCO @montypal]

Incredible to see the growth of @IBCG_BladderCA over 20y. At #IBCG26, @UroDocAsh highlights new members (incl @WesleyYipMD @AbhiTrip87 from @cityofhope), 🌎 site (28 countries!), publications (incl @EUplatinum highest rated article from @shilpaonc @UrogerliMD et al) & society collabs (@GTumorBoard @JSUO_official @TataMemorial @SIU_urology & more). Just brilliant!